Biotech firm Windtree Therapeutics has announced plans to purchase up to $700 million worth of BNB cryptocurrency, aiming to include it on its balance sheet. This decision follows the coin reaching a new all-time high price. Windtree plans to raise approximately $520 million to facilitate these purchases, having initially indicated a budget of $200 million. The funds will come from a $500 million equity line of credit and a separate $20 million agreement. CEO Jed Latkin emphasized the importance of this strategy subject to shareholder approval. BNB, the fifth-largest digital coin with a market cap of $106.9 billion, started as a token on the Ethereum network before transitioning to its own BNB Chain. The company aims to capitalize on trends seen in other publicly traded companies, some of which are also investing heavily in cryptocurrencies. Windtree's stock has seen considerable growth in recent weeks, coinciding with its crypto acquisition strategy, despite a slight dip in its value recently.

Source šŸ”—